Evidence map›Paper›PMID 40844549›Full record

ReviewJournal of gastroenterology2025

Evidence for imaging-based diagnosis of liver metastases from colorectal cancer.

Masakatsu Tsurusaki, Keitaro Sofue, Takamichi Murakami, Noboru Tanigawa

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Masakatsu TsurusakiDepartment of Radiology, Kansai Medical University Medical Center, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8503, Japan. mtsuru@dk2.so-net.ne.jp.ORCID 0000-0001-9894-4912
Keitaro SofueDepartment of Radiology, Kobe University Graduate School of Medicine, Kobe, Hyogo, 650-0017, Japan.ORCID 0000-0001-6132-1623
Takamichi MurakamiDepartment of Radiology, Kobe University Graduate School of Medicine, Kobe, Hyogo, 650-0017, Japan.ORCID 0000-0001-7782-548X
Noboru TanigawaDepartment of Radiology, Kansai Medical University, Hirakata, Osaka, 573-1010, Japan.ORCID 0000-0002-7283-3381

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastatic liver tumors are more common than primary liver cancers and are the most common liver malignancies. Performing B-mode ultrasonography and contrast-enhanced computed tomography is generally necessary for the diagnosis of liver metastases. However, various modalities, including dynamic contrast-enhanced computed tomography and magnetic resonance imaging using liver-specific contrast agents such as gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid, fluorodeoxyglucose positron emission tomography, and a combination of positron emission tomography and computed tomography, are also used. Improvements in imaging technology have made the detection of small liver masses possible, and liver metastases are being diagnosed more frequently, both before and after primary tumor treatment. The diagnosis of liver metastasis is related to treatment, and the benefits of liver resection depend on the primary tumor. For colorectal cancer, resection of liver metastases is beneficial. However, resection is not recommended for pancreatic or biliary tract cancers.

Indexed as

Colorectal NeoplasmsLiver NeoplasmsContrast MediaHumansMagnetic Resonance ImagingPositron-Emission TomographyTomography, X-Ray ComputedUltrasonographyContrast MediaArtificial intelligenceComputed tomographyDiagnostic imagingMagnetic resonance imagingMetastatic liver cancer

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.